Next Generation Sequencing Market- Current Impact to Make Big Changes by 2035 Roots Analysis recently published a report on the global Next Generation Sequencing Market Size, Share And Growth Trend Analysis Report By Region And Segmentation Forecasts (2026 - 2035) growth. With a focus on historical trends, current developments, and future projections, it offers a data-rich foundation for decision-makers, industry participants, and investors. The report includes both macro and micro-level insights, enabling readers to grasp key dynamics across segments, regions, and product categories. Market Size and Forecast Current Market Size:USD 9.8 Billion Future Market Size: USD 46.5 Billion CAGR: 18.9% Market Overview This growth is calculated based on observed trends, actual industry performance, and current developments in product usage and adoption. The study takes into account the challenges faced by key players and the general market structure, while avoiding speculative interpretations. It focuses on providing a clear picture of market performance across different regions and segments. This report supports strategic planning by delivering verified data, cross-segment comparisons, and actionable insights—available in both PDF and spreadsheet formats for ease of integration. Reference: https://www.rootsanalysis.com/reports/next-generation-sequencing/290.html Market Scope and Segmentation - Historical Trend: Since 2020 - Forecast Period: Till 2035 - Current Market Size: USD 9.8 Billion - Market Size in 2035: USD 46.5 Billion - CAGR (Till 2035): 18.9% - Type of Component • Consumables • Services • Instruments - Type of NGS Technique • Targeted Sequencing • / Whole Exome Sequencing • RNA Sequencing • Other Techniques - Type of Technology Used • Sequencing by Synthesis Technology • Ion Semiconductor Technology • Nanopore Sequencing Technology • Other Technologies - Application Area • Clinical Applications • Research and Applied Applications - Target Therapeutic Area • Oncological Disorders • Genetic Disorders • Reproductive Disorders • Other Therapeutic Areas - Purpose • Diagnosis • Risk Assessment • Presymptomatic Assessment • Screening • Other Purposes - End Users • Academic and Research Institutes • Hospitals and Clinics • Pharmaceutical and Biotechnology Companies • Other End Users - Geographical Regions • North America • Europe • Asia-Pacific • Middle East and North Africa • Latin America - Market in North America • US • Canada - Market in Europe • Germany • France • Italy • Spain • UK • Rest of Europe - Market in Asia-Pacific • China • India • Japan • South Korea • Singapore • Rest of Asia-Pacific - Market in Middle East and North Africa • Egypt • Israel • Saudi Arabia • Rest of Middle East and North Africa - Market in Latin America • Brazil • Argentina • Rest of Latin America - Key Next Generation Sequencing Companies Profiled • Admera Health • Applied Biological Materials • BGI Genomics • CD Genomics • DNA Link • Eurofins Genomics • Gene by Gene • GENEWIZ • MedGenome • Novogene • Psomagen • Veritas • Xcelris Labs - Key Next-generation Sequencing Technology Providers Profiled • Illumina • MGI Tech • Oxford Nanopore Technologies • Pacific Biosciences • Thermo Fisher Scientific - PowerPoint Presentation(Complimentary): Available - Customization Scope: 15% Free Customization - Excel Data Packs(Complimentary) • Market Landscape ( • Market Landscape ( • Technologies / Platforms Competitive Analysis • Patent Analysis • Clinical Trial Analysis • Big Pharma Analysis • Case Study Analysis • Market Forecast and Opportunity Analysis By Region North America, Europe, Asia-Pacific, Middle East and North Africa, Latin America This segmentation structure provides a clear framework for understanding market dynamics, segment-specific trends, and growth opportunities. Technological and Strategic Insights The Roots Analysis report includes a detailed assessment of: Technological advancements and R&D activity Innovations in formulation and delivery methods Marketing and distribution strategies Pricing models and cost structures Manufacturing capacities and supply chain trends These insights are presented neutrally, supported by empirical evidence and primary research validation. Key Market Players Profiles of prominent companies include: Admera Health, Applied Biological Materials, BGI Genomics, CD Genomics, DNA Link, Eurofins Genomics, Gene by Gene, GENEWIZ, MedGenome, Novogene, Psomagen, Veritas, Xcelris Labs Each profile highlights: Product portfolio and focus areas Operational footprint and regional presence Financial and strategic performance Recent developments (e.g., partnerships, market entries, acquisitions) Regional Insights Each region is analyzed based on: Historical and current market size Revenue performance Contribution to global share Strategic developments and regional trends Comparative insights across regions enable targeted market entry and expansion strategies. Report Structure Part 01: Market Overview Part 02: Market Size, by Regions Part 03: Market Revenue, by Countries Part 04: Market Competition, by Key Players Part 05: Company Profiles

https://univdatos.com/reports/next-generation-sequencing-in-agrigenomics-market

Whole Genome Sequencing Market Estimated to Experience a Hike in Growth by 2035 The global whole genome sequencing (WGS) market is poised for significant expansion, with its size estimated at USD 2.63 billion in 2025 and projected to reach USD 13.62 billion by 2035, growing at a robust compound annual growth rate (CAGR) of 17.9% over this period. This growth is driven by rapid technological advancements and increasing applications in medical research and precision medicine. Market Overview and Growth Drivers Whole genome sequencing is a comprehensive process that analyzes complete genomic information using advanced sequencing technologies such as next-generation sequencing and CRISPR-Cas genome editing. These technologies enable scientists to identify genetic mutations, alterations, and variations responsible for genetic disorders. WGS holds immense potential in disease detection, drug development, and biomarker characterization. The rising global burden of chronic diseases and cancer has intensified pharmaceutical companies' focus on genomic research to develop targeted precision medicines. WGS offers high accuracy and resolution in identifying genetic variants and understanding disease mechanisms, making it a critical tool in oncology research and personalized treatment planning. Market Segmentation The genome sequencing (WGS) market is segmented by product type, sequencing type, workflow, application, end user, and geography: - By Product Type: The market is divided into instruments, consumables, and services. Consumables dominate with a 66% share due to high demand for kits and reagents essential for genome sequencing and sample preparation. However, the services segment is expected to grow faster, driven by increasing reliance on genomic data interpretation and outsourcing of sequencing projects to reduce costs. - By Sequencing Type: Large whole genome sequencing accounts for 77% of the market, fueled by research on human genomes to study genetic variations and develop personalized therapeutics. Small whole genome sequencing, which focuses on smaller genomes like bacteria and viruses, is projected to grow substantially, supported by trends in single-cell omics and infectious disease research. Read More :- https://www.rootsanalysis.com/reports/whole-genome-sequencing-market.html

The Future of IVF: Emerging Trends in Genetic Testing It’s important to note that IVF has dramatically developed over the last few years mainly due to advances in the sphere of genetic diagnosis. These improvements are revolutionizing the IVF practice incorporating improvements in both precision and outcomes of fertility treatments. Turning to the future vision of genetic testing, several promising trends in reproductive medicine bring hope and new opportunities for prospective parents. Expanded Genetic Screening The new developments that have taken root in the trend of IVF are primarily focused on genetic screening. One of the invasive techniques that have increased the understanding of embryos in terms of chromosomal abnormalities and genetic disorders is PGT. Heretofore, PGT was employed for the detection of some genetic disorders including Down syndromes and other aneuploid conditions. Advancements in Genomic Technologies The ability to use advanced genomic technologies is still another feature that can be regarded as a major trend affecting the future of IVF. Out of all of these, next-generation sequencing (NGS) is most often associated with such developments. Personalized IVF Protocols The subject under discussion is the role of individualization in the field of reproductive health care steadily growing in importance. One of the benefits of Genetic testing is that IVF protocols can be developed according to the genetic makeup of the patient. AI Integration Genetic testing and IVF is one area where artificial intelligence popularly known as AI is expected to have a great future. AI solutions can find patterns in extensive data and make accurate predictions concerning a possible result. In the context of IVF, AI is useful in the selection of the best quality embryos characterized by good genetic qualities so that the success of implantation and subsequent pregnancy is enhanced. IVF at Pahlajanis’ Therefore, Pahlajanis’ Women’s Hospital, the Best IVF Center in Raipur, is one of the most famous reproductive health facilities focusing on IVF treatment and providing patients with sophisticated medical care. Raipur, Chhattisgarh based, occupies a prominent status in the medical world due to its superior genetic treatment, patient treatment plans and the staff involving experienced gynecologists. Read more: https://pahlajanis.com/